Market Outlook
The global Human Organs-on-Chips market size was valued at USD 69 million in 2022 and is forecast to a readjusted size of USD 154.4 million by 2029 with a CAGR of 12.2% during review period.
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumors), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Global key players of human organs-on-chips include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems and Draper Laboratory, etc. Top five players occupy for a share about 46%. North America is the largest market, with a share about 42%, followed by Asia-Pacific and Europe. In terms of product, liver-on-a-chip is the largest segment, with a share over 28%. In terms of end user, academic & research institutes is the largest market, with a share over 40%.
This report is a detailed and comprehensive analysis for global Human Organs-on-Chips market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Organs-on-Chips market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Organs-on-Chips market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Organs-on-Chips market size and forecasts, by Type and by End User, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Organs-on-Chips market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Organs-on-Chips
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Organs-on-Chips market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Segmentation By Type
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Segmentation By Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Segmentation By Region
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Human Organs-on-Chips Market in 2025?
The strengths lie in the ability of organs-on-chips to replicate human biology more accurately than traditional models, making drug testing, disease modeling, and personalized medicine more efficient. Additionally, the growing demand for alternative testing methods due to ethical concerns and regulatory pressures supports market growth.
What are the weaknesses of this market?
One major weakness is the high cost and complexity of developing and maintaining organs-on-chips systems. The technology is still relatively new, requiring significant investment in research and development. Furthermore, the lack of standardization and scalability can hinder widespread adoption.
What opportunities exist for the Human Organs-on-Chips Market?
Opportunities include expanding partnerships between biotech companies, academic institutions, and pharmaceutical firms to enhance the technology's capabilities. As regulatory bodies embrace alternative testing models, there is potential for increased demand in drug development, toxicity testing, and personalized medicine.
What threats could impact this market?
The primary threat is the potential competition from other emerging technologies, such as 3D bioprinting and AI-driven drug discovery models. Moreover, regulatory hurdles, ethical considerations, and the slow pace of integration into mainstream research practices could limit market growth.
Market PESTEL Analysis
What political factors influence the Human Organs-on-Chips Market in 2025?
Political factors include government regulations around ethical testing and animal welfare, which can boost the adoption of organs-on-chips for drug testing and research. Policies supporting innovation in healthcare and biotechnology, along with funding for research and development, are also vital.
How do economic factors impact the market?
Economic factors such as the increasing costs of drug development and healthcare drive the demand for more efficient and cost-effective alternatives, like organs-on-chips. However, the high initial cost of the technology could limit its accessibility to smaller firms or emerging markets.
What social factors are relevant for this market?
Social factors include the growing public concern for animal welfare and the demand for more ethical scientific practices. Additionally, the push for personalized medicine and better healthcare outcomes is shaping the demand for advanced testing models like organs-on-chips.
What technological factors affect the market?
Technological advancements in microfluidics, biomaterials, and tissue engineering are key drivers for the market. As these technologies evolve, organs-on-chips are becoming more sophisticated, enabling better simulations of human physiology and increasing their application in drug testing and disease modeling.
What environmental factors influence this market?
Environmental factors include the need for sustainable and less resource-intensive testing methods. Organs-on-chips offer an eco-friendlier alternative to traditional animal testing, aligning with global sustainability goals and reducing the environmental impact of biomedical research.
What legal factors are important for the Human Organs-on-Chips Market?
Legal factors involve regulatory approval processes for new biomedical technologies, intellectual property protection, and compliance with ethical standards in research. Regulatory bodies are increasingly focusing on the validation of alternative testing models, which could either enable or delay market growth.
Market SIPOC Analysis
Who are the suppliers in the Human Organs-on-Chips Market in 2025?
Suppliers include companies that provide the raw materials for chip fabrication, such as microfluidic devices, biomaterials, sensors, and biocompatible materials. Additionally, specialized manufacturers of advanced laboratory equipment and research institutions offering intellectual resources also play a key role.
What inputs are needed for the development of organs-on-chips?
Inputs required include advanced biomaterials, stem cells, tissues, and cells that can be cultured and incorporated into the chip systems. Additionally, funding, research expertise, and cutting-edge technologies in microfluidics, microelectronics, and 3D printing are essential for development.
What processes are involved in creating organs-on-chips?
Processes include designing and fabricating the chips using advanced microfluidic technology, integrating human cells or tissues, and conducting continuous research and development for improving the functionality of these systems. Quality control and validation against human physiological conditions are also critical steps in the process.
Who are the customers for organs-on-chips in 2025?
Customers include pharmaceutical and biotechnology companies seeking alternative methods for drug testing, universities and research institutions conducting studies on human biology, and regulatory bodies interested in the validation of these systems for clinical trials.
What outputs result from the development and use of organs-on-chips?
Outputs include functional organs-on-chips systems that simulate human organs for drug testing, toxicity studies, and disease modeling. The data generated from these chips can be used to optimize drug development, enhance personalized medicine, and reduce the reliance on animal testing.
Market Porter's Five Forces
How strong is the threat of new entrants in the Human Organs-on-Chips Market in 2025?
The threat of new entrants is moderate. While the market offers significant potential, the high costs associated with research, development, and regulatory approval act as barriers. However, as technology becomes more accessible and investments increase, new players may emerge, particularly with innovative solutions.
What is the bargaining power of suppliers in the Human Organs-on-Chips Market?
The bargaining power of suppliers is moderate. Suppliers of specialized materials and technologies have some leverage due to the advanced nature of the components required for organs-on-chips. However, as the market grows and more suppliers enter, their influence may decrease.
How intense is the competitive rivalry in the Human Organs-on-Chips Market?
Competitive rivalry is high. The market is attracting both established biotech companies and innovative startups, leading to intense competition. Companies are racing to develop more efficient and cost-effective solutions, pushing for differentiation through technological advancements and strategic partnerships.
What is the threat of substitute products or services in the Human Organs-on-Chips Market?
The threat of substitutes is moderate. While organs-on-chips offer unique benefits over traditional animal testing and cell cultures, alternative technologies like 3D bioprinting and AI-driven drug discovery could serve as substitutes. However, organs-on-chips remain one of the most promising options for simulating human biology.
What is the bargaining power of buyers in the Human Organs-on-Chips Market?
The bargaining power of buyers is moderate to high. Large pharmaceutical companies and research institutions, who are key customers, have substantial influence in driving demand for more tailored, cost-effective solutions. However, as the market expands and competition increases, buyers will likely have more options to choose from.
Market Upstream Analysis
What are the key suppliers in the upstream of the Human Organs-on-Chips Market?
Key suppliers include those providing essential raw materials such as biomaterials, cells, and tissues for developing organs-on-chips. Additionally, suppliers of microfluidic devices, sensors, and biocompatible materials are crucial for chip fabrication. Research institutions and technology providers also play a significant role.
What resources are needed for the upstream of this market?
Resources needed include high-quality biological samples (like stem cells), advanced laboratory technologies for cell culture and microfluidics, and specialized materials for creating the chips. Investment in research and development resources is also essential to advance the technology and ensure it meets regulatory standards.
What challenges exist in the upstream of the Human Organs-on-Chips Market?
Challenges include the high cost and complexity of sourcing and cultivating human cells or tissues that can accurately simulate organ functions. Additionally, ensuring the quality and consistency of the biomaterials used in the chips, along with the technological hurdles of integrating these materials, adds to the difficulty.
How does innovation affect the upstream in this market?
Innovation drives the upstream by creating more efficient ways to cultivate cells, develop advanced materials, and integrate technology into organs-on-chips systems. Innovations in 3D bioprinting, AI, and microfluidics technologies are improving the functionality and cost-effectiveness of these chips, benefiting the entire supply chain.
What role do partnerships play in the upstream of the Human Organs-on-Chips Market?
Partnerships are vital in the upstream, especially between biotech companies, research institutions, and material suppliers. These collaborations help with the development of new technologies, streamline the sourcing of high-quality materials, and provide the necessary expertise to overcome scientific and technical challenges.
Market Midstream Analysis
What are the key activities in the midstream of the Human Organs-on-Chips Market?
Key activities include the design and fabrication of the chips, integration of human tissues or cells, and the testing and optimization of these models for specific applications such as drug testing, toxicity screening, or disease modeling. Regulatory compliance and validation processes are also significant in this stage.
How does technology influence the midstream of this market?
Technology is central in the midstream, particularly in areas like microfluidics, 3D printing, and tissue engineering. Advancements in these technologies enable the creation of more complex and accurate models of human organs. The development of AI algorithms also helps in improving the efficiency and precision of organ simulations.
What are the main challenges in the midstream of the Human Organs-on-Chips Market?
Challenges in the midstream include ensuring the functionality and stability of organs-on-chips over time, as well as scalability issues in producing these models for widespread use. Additionally, integrating these systems with existing research workflows and meeting regulatory standards for clinical applications remain significant hurdles.
How do partnerships and collaborations impact the midstream of this market?
Partnerships and collaborations play a key role in advancing the midstream by pooling resources and expertise to overcome technical challenges. Collaborations between academic institutions, research organizations, and biotech companies help accelerate the development and commercial viability of organs-on-chips technologies.
What are the key drivers for growth in the midstream of the market?
The increasing demand for alternative drug testing models, combined with advancements in biotechnology and microfluidics, is a key driver. The push for personalized medicine and more accurate disease modeling also spurs growth in this stage, as organs-on-chips provide a more reliable and human-relevant testing platform.
Market Downstream Analysis
Who are the key players in the downstream of the Human Organs-on-Chips Market?
Key players in the downstream include pharmaceutical and biotech companies, research institutions, regulatory bodies, and end-users such as hospitals and clinical laboratories. These entities use organs-on-chips for drug development, toxicity testing, and personalized medicine research.
What are the main activities in the downstream of this market?
Main activities in the downstream involve applying organs-on-chips in drug discovery, clinical trials, and disease modeling. These activities focus on testing new compounds, assessing the safety and efficacy of treatments, and advancing personalized medicine solutions. Additionally, regulatory bodies work to validate and approve these systems for clinical use.
What challenges exist in the downstream of the Human Organs-on-Chips Market?
Challenges in the downstream include the integration of organs-on-chips into existing research pipelines, as well as the need for standardization and validation of these models for regulatory approval. Furthermore, widespread adoption is limited by cost and the relatively early stage of technology adoption in clinical settings.
How do regulations affect the downstream of this market?
Regulations play a crucial role in the downstream by determining how organs-on-chips can be used in drug testing, clinical trials, and healthcare applications. Regulatory bodies must validate these models for clinical use, which can be a time-consuming process. Compliance with ethical standards for testing and patient safety is also essential.
What are the growth drivers in the downstream of the Human Organs-on-Chips Market?
Growth drivers in the downstream include the rising demand for more accurate and ethical alternatives to animal testing, the push for personalized medicine, and the increasing need for more efficient drug development processes. As pharmaceutical companies and research institutions adopt organs-on-chips for their human-relevant testing capabilities, demand is expected to grow.
Chapter 1, to describe Human Organs-on-Chips product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Organs-on-Chips, with price, sales, revenue and global market share of Human Organs-on-Chips from 2018 to 2023.
Chapter 3, the Human Organs-on-Chips competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Organs-on-Chips breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and end user, with sales market share and growth rate by type, end user, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Organs-on-Chips market forecast, by regions, type and end user, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Organs-on-Chips.
Chapter 14 and 15, to describe Human Organs-on-Chips sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Human Organs-on-Chips
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Organs-on-Chips Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Brain-on-a-chip
1.3.3 Liver-on-a-chip
1.3.4 Kidney-on-a-chip
1.3.5 Lung-on-a-chip
1.3.6 Heart-on-a-chip
1.3.7 Intestine-on-a-chip
1.3.8 Vessel-on-a-chip
1.3.9 Other Organs
1.4 Market Analysis by End User
1.4.1 Overview: Global Human Organs-on-Chips Consumption Value by End User: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical & Biotechnology Companies
1.4.3 Academic & Research Institutes
1.4.4 Cosmetics Industry
1.4.5 Others
1.5 Global Human Organs-on-Chips Market Size & Forecast
1.5.1 Global Human Organs-on-Chips Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Organs-on-Chips Sales Quantity (2018-2029)
1.5.3 Global Human Organs-on-Chips Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Emulate
2.1.1 Emulate Details
2.1.2 Emulate Major Business
2.1.3 Emulate Human Organs-on-Chips Product and Services
2.1.4 Emulate Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Emulate Recent Developments/Updates
2.2 TissUse
2.2.1 TissUse Details
2.2.2 TissUse Major Business
2.2.3 TissUse Human Organs-on-Chips Product and Services
2.2.4 TissUse Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 TissUse Recent Developments/Updates
2.3 Hesperos
2.3.1 Hesperos Details
2.3.2 Hesperos Major Business
2.3.3 Hesperos Human Organs-on-Chips Product and Services
2.3.4 Hesperos Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Hesperos Recent Developments/Updates
2.4 CN Bio Innovations
2.4.1 CN Bio Innovations Details
2.4.2 CN Bio Innovations Major Business
2.4.3 CN Bio Innovations Human Organs-on-Chips Product and Services
2.4.4 CN Bio Innovations Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 CN Bio Innovations Recent Developments/Updates
2.5 Tara Biosystems
2.5.1 Tara Biosystems Details
2.5.2 Tara Biosystems Major Business
2.5.3 Tara Biosystems Human Organs-on-Chips Product and Services
2.5.4 Tara Biosystems Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Tara Biosystems Recent Developments/Updates
2.6 Draper Laboratory
2.6.1 Draper Laboratory Details
2.6.2 Draper Laboratory Major Business
2.6.3 Draper Laboratory Human Organs-on-Chips Product and Services
2.6.4 Draper Laboratory Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Draper Laboratory Recent Developments/Updates
2.7 Mimetas
2.7.1 Mimetas Details
2.7.2 Mimetas Major Business
2.7.3 Mimetas Human Organs-on-Chips Product and Services
2.7.4 Mimetas Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Mimetas Recent Developments/Updates
2.8 Nortis
2.8.1 Nortis Details
2.8.2 Nortis Major Business
2.8.3 Nortis Human Organs-on-Chips Product and Services
2.8.4 Nortis Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Nortis Recent Developments/Updates
2.9 Micronit Microtechnologies B.V.
2.9.1 Micronit Microtechnologies B.V. Details
2.9.2 Micronit Microtechnologies B.V. Major Business
2.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Product and Services
2.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Micronit Microtechnologies B.V. Recent Developments/Updates
2.10 Kirkstall
2.10.1 Kirkstall Details
2.10.2 Kirkstall Major Business
2.10.3 Kirkstall Human Organs-on-Chips Product and Services
2.10.4 Kirkstall Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Kirkstall Recent Developments/Updates
2.11 Cherry Biotech SAS
2.11.1 Cherry Biotech SAS Details
2.11.2 Cherry Biotech SAS Major Business
2.11.3 Cherry Biotech SAS Human Organs-on-Chips Product and Services
2.11.4 Cherry Biotech SAS Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cherry Biotech SAS Recent Developments/Updates
2.12 Else Kooi Laboratory
2.12.1 Else Kooi Laboratory Details
2.12.2 Else Kooi Laboratory Major Business
2.12.3 Else Kooi Laboratory Human Organs-on-Chips Product and Services
2.12.4 Else Kooi Laboratory Human Organs-on-Chips Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Else Kooi Laboratory Recent Developments/Updates
3 Competitive Environment: Human Organs-on-Chips by Manufacturer
3.1 Global Human Organs-on-Chips Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Organs-on-Chips Revenue by Manufacturer (2018-2023)
3.3 Global Human Organs-on-Chips Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Organs-on-Chips by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Organs-on-Chips Manufacturer Market Share in 2022
3.4.2 Top 6 Human Organs-on-Chips Manufacturer Market Share in 2022
3.5 Human Organs-on-Chips Market: Overall Company Footprint Analysis
3.5.1 Human Organs-on-Chips Market: Region Footprint
3.5.2 Human Organs-on-Chips Market: Company Product Type Footprint
3.5.3 Human Organs-on-Chips Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Organs-on-Chips Market Size by Region
4.1.1 Global Human Organs-on-Chips Sales Quantity by Region (2018-2029)
4.1.2 Global Human Organs-on-Chips Consumption Value by Region (2018-2029)
4.1.3 Global Human Organs-on-Chips Average Price by Region (2018-2029)
4.2 North America Human Organs-on-Chips Consumption Value (2018-2029)
4.3 Europe Human Organs-on-Chips Consumption Value (2018-2029)
4.4 Asia-Pacific Human Organs-on-Chips Consumption Value (2018-2029)
4.5 South America Human Organs-on-Chips Consumption Value (2018-2029)
4.6 Middle East and Africa Human Organs-on-Chips Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Organs-on-Chips Sales Quantity by Type (2018-2029)
5.2 Global Human Organs-on-Chips Consumption Value by Type (2018-2029)
5.3 Global Human Organs-on-Chips Average Price by Type (2018-2029)
6 Market Segment by End User
6.1 Global Human Organs-on-Chips Sales Quantity by End User (2018-2029)
6.2 Global Human Organs-on-Chips Consumption Value by End User (2018-2029)
6.3 Global Human Organs-on-Chips Average Price by End User (2018-2029)
7 North America
7.1 North America Human Organs-on-Chips Sales Quantity by Type (2018-2029)
7.2 North America Human Organs-on-Chips Sales Quantity by End User (2018-2029)
7.3 North America Human Organs-on-Chips Market Size by Country
7.3.1 North America Human Organs-on-Chips Sales Quantity by Country (2018-2029)
7.3.2 North America Human Organs-on-Chips Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Organs-on-Chips Sales Quantity by Type (2018-2029)
8.2 Europe Human Organs-on-Chips Sales Quantity by End User (2018-2029)
8.3 Europe Human Organs-on-Chips Market Size by Country
8.3.1 Europe Human Organs-on-Chips Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Organs-on-Chips Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Organs-on-Chips Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Organs-on-Chips Sales Quantity by End User (2018-2029)
9.3 Asia-Pacific Human Organs-on-Chips Market Size by Region
9.3.1 Asia-Pacific Human Organs-on-Chips Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Organs-on-Chips Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Organs-on-Chips Sales Quantity by Type (2018-2029)
10.2 South America Human Organs-on-Chips Sales Quantity by End User (2018-2029)
10.3 South America Human Organs-on-Chips Market Size by Country
10.3.1 South America Human Organs-on-Chips Sales Quantity by Country (2018-2029)
10.3.2 South America Human Organs-on-Chips Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Organs-on-Chips Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Organs-on-Chips Sales Quantity by End User (2018-2029)
11.3 Middle East & Africa Human Organs-on-Chips Market Size by Country
11.3.1 Middle East & Africa Human Organs-on-Chips Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Organs-on-Chips Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Organs-on-Chips Market Drivers
12.2 Human Organs-on-Chips Market Restraints
12.3 Human Organs-on-Chips Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Organs-on-Chips and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Organs-on-Chips
13.3 Human Organs-on-Chips Production Process
13.4 Human Organs-on-Chips Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Organs-on-Chips Typical Distributors
14.3 Human Organs-on-Chips Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Human Organs-on-Chips Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Organs-on-Chips Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
Table 3. Emulate Basic Information, Manufacturing Base and Competitors
Table 4. Emulate Major Business
Table 5. Emulate Human Organs-on-Chips Product and Services
Table 6. Emulate Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Emulate Recent Developments/Updates
Table 8. TissUse Basic Information, Manufacturing Base and Competitors
Table 9. TissUse Major Business
Table 10. TissUse Human Organs-on-Chips Product and Services
Table 11. TissUse Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. TissUse Recent Developments/Updates
Table 13. Hesperos Basic Information, Manufacturing Base and Competitors
Table 14. Hesperos Major Business
Table 15. Hesperos Human Organs-on-Chips Product and Services
Table 16. Hesperos Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Hesperos Recent Developments/Updates
Table 18. CN Bio Innovations Basic Information, Manufacturing Base and Competitors
Table 19. CN Bio Innovations Major Business
Table 20. CN Bio Innovations Human Organs-on-Chips Product and Services
Table 21. CN Bio Innovations Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. CN Bio Innovations Recent Developments/Updates
Table 23. Tara Biosystems Basic Information, Manufacturing Base and Competitors
Table 24. Tara Biosystems Major Business
Table 25. Tara Biosystems Human Organs-on-Chips Product and Services
Table 26. Tara Biosystems Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Tara Biosystems Recent Developments/Updates
Table 28. Draper Laboratory Basic Information, Manufacturing Base and Competitors
Table 29. Draper Laboratory Major Business
Table 30. Draper Laboratory Human Organs-on-Chips Product and Services
Table 31. Draper Laboratory Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Draper Laboratory Recent Developments/Updates
Table 33. Mimetas Basic Information, Manufacturing Base and Competitors
Table 34. Mimetas Major Business
Table 35. Mimetas Human Organs-on-Chips Product and Services
Table 36. Mimetas Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Mimetas Recent Developments/Updates
Table 38. Nortis Basic Information, Manufacturing Base and Competitors
Table 39. Nortis Major Business
Table 40. Nortis Human Organs-on-Chips Product and Services
Table 41. Nortis Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Nortis Recent Developments/Updates
Table 43. Micronit Microtechnologies B.V. Basic Information, Manufacturing Base and Competitors
Table 44. Micronit Microtechnologies B.V. Major Business
Table 45. Micronit Microtechnologies B.V. Human Organs-on-Chips Product and Services
Table 46. Micronit Microtechnologies B.V. Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Micronit Microtechnologies B.V. Recent Developments/Updates
Table 48. Kirkstall Basic Information, Manufacturing Base and Competitors
Table 49. Kirkstall Major Business
Table 50. Kirkstall Human Organs-on-Chips Product and Services
Table 51. Kirkstall Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Kirkstall Recent Developments/Updates
Table 53. Cherry Biotech SAS Basic Information, Manufacturing Base and Competitors
Table 54. Cherry Biotech SAS Major Business
Table 55. Cherry Biotech SAS Human Organs-on-Chips Product and Services
Table 56. Cherry Biotech SAS Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Cherry Biotech SAS Recent Developments/Updates
Table 58. Else Kooi Laboratory Basic Information, Manufacturing Base and Competitors
Table 59. Else Kooi Laboratory Major Business
Table 60. Else Kooi Laboratory Human Organs-on-Chips Product and Services
Table 61. Else Kooi Laboratory Human Organs-on-Chips Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Else Kooi Laboratory Recent Developments/Updates
Table 63. Global Human Organs-on-Chips Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Human Organs-on-Chips Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Human Organs-on-Chips Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Human Organs-on-Chips, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Human Organs-on-Chips Production Site of Key Manufacturer
Table 68. Human Organs-on-Chips Market: Company Product Type Footprint
Table 69. Human Organs-on-Chips Market: Company Product Application Footprint
Table 70. Human Organs-on-Chips New Market Entrants and Barriers to Market Entry
Table 71. Human Organs-on-Chips Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Human Organs-on-Chips Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Human Organs-on-Chips Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Human Organs-on-Chips Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Human Organs-on-Chips Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Human Organs-on-Chips Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Human Organs-on-Chips Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Human Organs-on-Chips Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Human Organs-on-Chips Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Human Organs-on-Chips Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Human Organs-on-Chips Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Human Organs-on-Chips Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Human Organs-on-Chips Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Human Organs-on-Chips Sales Quantity by End User (2018-2023) & (K Units)
Table 85. Global Human Organs-on-Chips Sales Quantity by End User (2024-2029) & (K Units)
Table 86. Global Human Organs-on-Chips Consumption Value by End User (2018-2023) & (USD Million)
Table 87. Global Human Organs-on-Chips Consumption Value by End User (2024-2029) & (USD Million)
Table 88. Global Human Organs-on-Chips Average Price by End User (2018-2023) & (US$/Unit)
Table 89. Global Human Organs-on-Chips Average Price by End User (2024-2029) & (US$/Unit)
Table 90. North America Human Organs-on-Chips Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Human Organs-on-Chips Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Human Organs-on-Chips Sales Quantity by End User (2018-2023) & (K Units)
Table 93. North America Human Organs-on-Chips Sales Quantity by End User (2024-2029) & (K Units)
Table 94. North America Human Organs-on-Chips Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Human Organs-on-Chips Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Human Organs-on-Chips Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Human Organs-on-Chips Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Human Organs-on-Chips Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Human Organs-on-Chips Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Human Organs-on-Chips Sales Quantity by End User (2018-2023) & (K Units)
Table 101. Europe Human Organs-on-Chips Sales Quantity by End User (2024-2029) & (K Units)
Table 102. Europe Human Organs-on-Chips Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Human Organs-on-Chips Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Human Organs-on-Chips Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Human Organs-on-Chips Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Human Organs-on-Chips Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Human Organs-on-Chips Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Human Organs-on-Chips Sales Quantity by End User (2018-2023) & (K Units)
Table 109. Asia-Pacific Human Organs-on-Chips Sales Quantity by End User (2024-2029) & (K Units)
Table 110. Asia-Pacific Human Organs-on-Chips Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Human Organs-on-Chips Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Human Organs-on-Chips Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Human Organs-on-Chips Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Human Organs-on-Chips Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Human Organs-on-Chips Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Human Organs-on-Chips Sales Quantity by End User (2018-2023) & (K Units)
Table 117. South America Human Organs-on-Chips Sales Quantity by End User (2024-2029) & (K Units)
Table 118. South America Human Organs-on-Chips Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Human Organs-on-Chips Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Human Organs-on-Chips Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Human Organs-on-Chips Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Human Organs-on-Chips Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Human Organs-on-Chips Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Human Organs-on-Chips Sales Quantity by End User (2018-2023) & (K Units)
Table 125. Middle East & Africa Human Organs-on-Chips Sales Quantity by End User (2024-2029) & (K Units)
Table 126. Middle East & Africa Human Organs-on-Chips Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Human Organs-on-Chips Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Human Organs-on-Chips Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Human Organs-on-Chips Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Human Organs-on-Chips Raw Material
Table 131. Key Manufacturers of Human Organs-on-Chips Raw Materials
Table 132. Human Organs-on-Chips Typical Distributors
Table 133. Human Organs-on-Chips Typical Customers
List of Figures
Figure 1. Human Organs-on-Chips Picture
Figure 2. Global Human Organs-on-Chips Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Organs-on-Chips Consumption Value Market Share by Type in 2022
Figure 4. Brain-on-a-chip Examples
Figure 5. Liver-on-a-chip Examples
Figure 6. Kidney-on-a-chip Examples
Figure 7. Lung-on-a-chip Examples
Figure 8. Heart-on-a-chip Examples
Figure 9. Intestine-on-a-chip Examples
Figure 10. Vessel-on-a-chip Examples
Figure 11. Other Organs Examples
Figure 12. Global Human Organs-on-Chips Consumption Value by End User, (USD Million), 2018 & 2022 & 2029
Figure 13. Global Human Organs-on-Chips Consumption Value Market Share by End User in 2022
Figure 14. Pharmaceutical & Biotechnology Companies Examples
Figure 15. Academic & Research Institutes Examples
Figure 16. Cosmetics Industry Examples
Figure 17. Others Examples
Figure 18. Global Human Organs-on-Chips Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 19. Global Human Organs-on-Chips Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 20. Global Human Organs-on-Chips Sales Quantity (2018-2029) & (K Units)
Figure 21. Global Human Organs-on-Chips Average Price (2018-2029) & (US$/Unit)
Figure 22. Global Human Organs-on-Chips Sales Quantity Market Share by Manufacturer in 2022
Figure 23. Global Human Organs-on-Chips Consumption Value Market Share by Manufacturer in 2022
Figure 24. Producer Shipments of Human Organs-on-Chips by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 25. Top 3 Human Organs-on-Chips Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Top 6 Human Organs-on-Chips Manufacturer (Consumption Value) Market Share in 2022
Figure 27. Global Human Organs-on-Chips Sales Quantity Market Share by Region (2018-2029)
Figure 28. Global Human Organs-on-Chips Consumption Value Market Share by Region (2018-2029)
Figure 29. North America Human Organs-on-Chips Consumption Value (2018-2029) & (USD Million)
Figure 30. Europe Human Organs-on-Chips Consumption Value (2018-2029) & (USD Million)
Figure 31. Asia-Pacific Human Organs-on-Chips Consumption Value (2018-2029) & (USD Million)
Figure 32. South America Human Organs-on-Chips Consumption Value (2018-2029) & (USD Million)
Figure 33. Middle East & Africa Human Organs-on-Chips Consumption Value (2018-2029) & (USD Million)
Figure 34. Global Human Organs-on-Chips Sales Quantity Market Share by Type (2018-2029)
Figure 35. Global Human Organs-on-Chips Consumption Value Market Share by Type (2018-2029)
Figure 36. Global Human Organs-on-Chips Average Price by Type (2018-2029) & (US$/Unit)
Figure 37. Global Human Organs-on-Chips Sales Quantity Market Share by End User (2018-2029)
Figure 38. Global Human Organs-on-Chips Consumption Value Market Share by End User (2018-2029)
Figure 39. Global Human Organs-on-Chips Average Price by End User (2018-2029) & (US$/Unit)
Figure 40. North America Human Organs-on-Chips Sales Quantity Market Share by Type (2018-2029)
Figure 41. North America Human Organs-on-Chips Sales Quantity Market Share by End User (2018-2029)
Figure 42. North America Human Organs-on-Chips Sales Quantity Market Share by Country (2018-2029)
Figure 43. North America Human Organs-on-Chips Consumption Value Market Share by Country (2018-2029)
Figure 44. United States Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Canada Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Mexico Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Europe Human Organs-on-Chips Sales Quantity Market Share by Type (2018-2029)
Figure 48. Europe Human Organs-on-Chips Sales Quantity Market Share by End User (2018-2029)
Figure 49. Europe Human Organs-on-Chips Sales Quantity Market Share by Country (2018-2029)
Figure 50. Europe Human Organs-on-Chips Consumption Value Market Share by Country (2018-2029)
Figure 51. Germany Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. France Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. United Kingdom Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Russia Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Italy Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Asia-Pacific Human Organs-on-Chips Sales Quantity Market Share by Type (2018-2029)
Figure 57. Asia-Pacific Human Organs-on-Chips Sales Quantity Market Share by End User (2018-2029)
Figure 58. Asia-Pacific Human Organs-on-Chips Sales Quantity Market Share by Region (2018-2029)
Figure 59. Asia-Pacific Human Organs-on-Chips Consumption Value Market Share by Region (2018-2029)
Figure 60. China Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Japan Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Korea Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. India Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Southeast Asia Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Australia Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. South America Human Organs-on-Chips Sales Quantity Market Share by Type (2018-2029)
Figure 67. South America Human Organs-on-Chips Sales Quantity Market Share by End User (2018-2029)
Figure 68. South America Human Organs-on-Chips Sales Quantity Market Share by Country (2018-2029)
Figure 69. South America Human Organs-on-Chips Consumption Value Market Share by Country (2018-2029)
Figure 70. Brazil Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Argentina Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Middle East & Africa Human Organs-on-Chips Sales Quantity Market Share by Type (2018-2029)
Figure 73. Middle East & Africa Human Organs-on-Chips Sales Quantity Market Share by End User (2018-2029)
Figure 74. Middle East & Africa Human Organs-on-Chips Sales Quantity Market Share by Region (2018-2029)
Figure 75. Middle East & Africa Human Organs-on-Chips Consumption Value Market Share by Region (2018-2029)
Figure 76. Turkey Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Egypt Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Saudi Arabia Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. South Africa Human Organs-on-Chips Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 80. Human Organs-on-Chips Market Drivers
Figure 81. Human Organs-on-Chips Market Restraints
Figure 82. Human Organs-on-Chips Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Human Organs-on-Chips in 2022
Figure 85. Manufacturing Process Analysis of Human Organs-on-Chips
Figure 86. Human Organs-on-Chips Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
